Cost-effective market access strategy for medical technologies in Europe
A holistic approach to reimbursement strategies trusted by global market leaders and SMEs
Recent news and posts
New procedure codes were added to Belgian Nomenclature in May 2024
On May 1, 2024, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated several articles of the Nomenclature, including the introduction of new procedure codes with reimbursement fees and associated conditions concerning pulmonary, endoscopy and in-vitro diagnostic fields. Some examples of newly added codes are presented below.
Several new codes were introduced in Article 20 "Internal medicine", including the following:
- 471892-471903 Bronchoscopy with the placement of a stent or endobronchial valve or endobronchial clip;
- 471914-471925 Bronchoscopy with peripheral lung biopsy (including possible fluoroscopy) with the use of ultrasound-guided navigation or electromagnetic navigation.
One new code was added in Article 24, "Clinical Biology": 542990-543001 Protein electrophoresis with curve and calculation in patients with monoclonal gammopathy #(Maximum 1) (Cumulation rule 11).
See the full details here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.